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The protein product of the 39k gene of Autographa californica nuclear polyhedrosis virus is thought to be important for viral
replication because of its association with the virogenic stroma and its role in activation of late gene expression. Transient
expression assays showed that addition of a DNA fragment encoding a 58-amino-acid polypeptide increased expression of a 39k
reporter plasmid. This stimulation was dependent on cotransfection of a plasmid encoding IE1. Cotransfection of this gene, orf121,
also stimulated ie1 expression, and the activation of ie1 was even more dramatic in the presence of IE1. These data suggested
that ORF121 stimulated 39k expression by upregulation of IE1 expression. Activation of 39k by ORF121 and the viral transcription
factor IE2 was additive, while activation by ORF121 and the apoptotic suppressor P35 was synergistic. Cotransfection of p39cat
and pIE1 with plasmids encoding ORF121, IE2, and P35 stimulated 39cat expression more than 100-fold compared to cells
transfected with only p39cat and pIE1. These data suggest that IE2 and ORF121 work by similar mechanisms and indirectly activate
p39cat by increasing IE1 expression, while P35 increases 39cat expression by a different mechanism. © 1998 Academic Press
INTRODUCTION
The 39k gene of Autographa californica nuclear polyhe-
drosis virus (AcNPV) encodes a protein called pp31, a non-
specific DNA-binding protein that associates with the viro-
genic stroma (Guarino et al., 1992; Wilson and Price, 1988).
pp31 is highly expressed throughout infection and is dy-
namically regulated by phosphorylation (Broussard et al.,
1996). Recent studies indicate that pp31 is required for late
gene expression in transient assays and that it acts at the
level of either transcription or mRNA stability (Lu and Miller,
1995). Taken together, these observations suggest that
pp31 plays an important role in the viral life cycle.
Expression of pp31 is regulated by tandem early and late
promoters (Guarino and Smith, 1992). Transcription from the
late promoter requires the highly conserved TAAG motif
(Guarino and Smith, 1992) and is mediated by the viral-induced
RNA polymerase (Xu et al., 1995). Transcription of 39k during
the early phase is regulated by transacting viral factors, and
the early promoter consists of dual TATA boxes, a CAGT motif,
and upstream regulatory elements (Guarino and Smith, 1992).
Expression of 39k in transient assays is dependent on the viral
trans-regulatory protein IE1 (Guarino and Summers, 1986a).
IE1-dependent activation of 39k is increased 1000-fold by the
presence of a viral enhancer element cis-linked to the 39k
promoter (Guarino and Summers, 1986b). Transient expres-
sion from the 39k promoter is also increased by the addition of
plasmids encoding the viral protein IE2 (Carson et al., 1988). In
vitro transcription experiments have shown that IE2 is a tran-
scription factor that activates the ie1 promoter (Yoo and
Guarino, 1994). Thus IE2 indirectly stimulates 39k expression
by increasing the levels of IE1 which are rate-limiting for
transcription of 39k.
Previously, we used a subtractive transient expression
assay to identify additional factors that regulate expres-
sion of the 39k promoter (Gong and Guarino, 1994). We
cotransfected a library of clones of viral DNA with a
reporter plasmid (39cat) containing the chloramphenicol
acetyltransferase (CAT) gene under the control of the 39k
promoter. Then we determined the effect of individually
subtracting clones from the transient expression assays.
This led to the observation that the P35 protein of AcNPV
increased expression of the 39k promoter (Gong and
Guarino, 1994). P35 has previously been identified as an
inhibitor of programmed cell death (apoptosis) which is
induced by AcNPV infection (Clem and Miller, 1993).
These experiments also suggested that the XhoI-G frag-
ment of AcNPV DNA contained a gene that potentially
regulated 39cat. Here we present data showing that the
product of the orf121 gene stimulates 39k gene expres-
sion. ORF121 also increased ie1 expression, suggesting
that ORF121 regulates 39k expression indirectly. Further-
more, activation of 39k by IE2 and ORF121 was additive,
while activation by ORF121 and P35 was more than
additive. These data indicate that IE2 and ORF121 work
by a similar mechanism and indirectly activate 39cat by
increasing IE1 expression. P35 activates 39k through a
different mechanism, most likely by prolonging the via-
bility of transfected cells.
1 To whom reprint requests should be addressed. Fax: (409) 845-
9274. E-mail: lguarino@bioch.tamu.edu.
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RESULTS
ORF121 increased 39cat expression
We tested the effect of individually cotransfecting
clones of viral DNA and the reporter plasmid p39cat in
the presence of pNheIE1. We found that the addition of
the genomic clone pXhoI-G (Fig. 1B, lane 2) stimulated
CAT activity compared to the level obtained with pN-
heIE1 alone (Fig. 1B, lane 1). This is contradictory to the
results we observed when pXhoI-G was assayed in the
context of a cloned library (Gong and Guarino, 1994).
However, this difference was consistently observed us-
ing three different DNA preparations. Therefore, we de-
cided to concentrate on the stimulatory factor and did not
further investigate the inhibition.
To map the trans-active factor within pXhoI-G, 1 mg
each of 39cat and pNheIE1 was cotransfected with vec-
tor (as negative control), or pXhoI-G (as positive control),
or different subclones of pXhoI-G. Addition of subclones
pPstI-L or pPstL-AHD stimulated CAT activity to levels
similar to that observed when pXhoI-G was added (Fig.
1B, lanes 4 and 6).
FIG. 1. Mapping of a stimulatory factor in the XhoI-G fragment of AcNPV. (A) Genomic map of AcNPV. The locations of the cloned fragments used
in the complete library are presented above the genomic map. A diagram of the XhoI-G region is shown below. The orientations of ORFs 120, 121,
and 122 are indicated by arrowheads. Restriction sites discussed in the text are indicated. (B) Transient expression mapping of XhoI-G. S. frugiperda
cells were cotransfected with 1 mg each of 39cat and pNheIE1 plus 5 mg of the indicated plasmids. CAT assays were performed by tlc separation
of input chloramphenicol (CM) and acetylated products (Ac-CM). The relative amounts of acetylated product formed for each assay are indicated
above the autoradiograph. All quantitations were performed under conditions where the total amount of acetylated product was less than 30% of the
input substrate.
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pPstL-AHD contains only three open reading frames (Ayres
et al., 1994; Fig. 2). To determine which of these (ORF120, 121,
or 122; see Fig. 1A) was responsible for the stimulation of
39cat expression, additional clones were used in cotransfec-
tion experiments with p39cat and pNheIE1. Both pPstL-
EcoRV/FS and pPst-AHDNcoI/FS, which contain frameshifts in
ORF120 or ORF122, respectively, stimulated CAT activity (Fig.
1B, lanes 7 and 8). This suggested that ORF121 encoded the
trans-active factor. ORF121 does not contain a unique restric-
tion site which could be used for the construction of a frame-
shift mutant, and thus the action of ORF121 could not be tested
by frameshift analysis. Therefore, the 370-bp AflIII fragment
that contains ORF121 and ORF122 in opposite orientations
was cloned into the HincII site of pIE1HcII. In one orientation,
the ie1 promoter directs the transcription of ORF121; this con-
struct is called pIE-ORF121. In the opposite orientation, ie1
directs transcription of ORF122, and this construct is referred
to as pIE-ORF122. Addition of pIE-ORF121 increased CAT ac-
tivity (about fivefold compared to addition of pIE-ORF122 or
pIE1HcII), similar to the level observed in the presence of
pXhoI-G (see Fig. 1B, compare lanes 2, 9, 10, and 11). Since the
addition of pIE-ORF122 resulted in levels of CAT activity similar
FIG. 2. Nucleotide sequence of the ORF121 gene. The sequence of AcNPV is shown with selected restriction sites indicated above the sequence,
and the predicted proteins sequences for ORF120, ORF121, and ORF122 are shown below. The sequence is numbered according to Ayres et al. (2).
The 59 terminus of orf121 mRNA is indicated by a right arrowhead. A palindromic sequence with similarity to hr regions of AcNPV DNA (Ayres et al.,
1994) is noted by a double underline. The sequence corresponding to the oligonucleotide used for primer extension is indicated by a dotted underline.
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to that of pIE1HcII (negative control), the possibility that cis
element(s) in the 370-bp AflIII fragment contributed to the
activation of 39cat can be excluded. Taken together, the above
results indicated that activation of 39cat expression was
caused by the product of orf121.
Transcription of orf121 during viral infection
To study the expression of orf121 in AcNPV-infected
cells, a strand-specific S1 nuclease analysis was per-
formed with RNA harvested at different times postinfec-
tion. Three protected fragments of approximately 82, 170,
and 420 nucleotides (nt) were detected after S1 nuclease
digestion (Fig 3A). The 59 end of the protected 82-nt
fragment is downstream of the start codon orf121, and
thus this transcript could not direct the synthesis of
ORF121. Transcripts initiating at the 59 end of the pro-
tected 420-nt fragment contain ORF121; however,
ORF120 is the 59 proximal ORF and so these transcripts
probably direct translation of ORF120. Thus the transcrip-
tion start site of ORF121 mRNA presumably maps to the
59 end of the 170-nt fragment. The orf121 transcripts were
first detected at 4 h postinfection and reached maximal
levels by 6 h postinfection. Transcript levels were steady
between 12 and 18 h postinfection, but were undetect-
able thereafter. Using the same RNAs, ie1 and ie0 tran-
scripts were detected by 2 h postinfection. Transcripts of
ie0 declined and were undetectable after 6 h postinfec-
tion. ie1 transcripts declined and were undetectable in
the 12- and 18-h postinfection samples, but then late ie1
transcript resumed during the late phase. These results
indicate that transcription of ORF121 was temporally con-
trolled and was limited to the early phase of viral infec-
tion.
The exact transcription start site for orf121 was then
determined by primer extension analysis (data not
shown). The 59 ends of orf121 were heterogeneous and
initiated between -40 and -44 relative to the translation
initiation codon. These transcripts initiate near the left-
ward end of a palindromic sequence previously noted by
Ayres et al., (1994). This sequence matches in 21 of 24
positions with the central palindromes of homologous
regions (hrs) in AcNPV. A typical hr repeat contains a
centrally located EcoRI site. The palindrome upstream of
orf121, however, does not contain an EcoRI site because
one of the mismatches occurs in this region.
ORF121 encodes a polypeptide
To confirm that the orf121 transcripts encoded a
polypeptide, a 370-bp AflIII–AflIII DNA fragment which
contained the entire coding region of ORF121 (see Fig. 2)
FIG. 3. Temporal expression of ORF121 during viral infection. (A)
Total cellular RNA was isolated from AcNPV-infected S. frugiperda cells
at the indicated times postinfection as described previously. The 59 end
of the transcripts was mapped by S1 nuclease analysis using a PstI–
NspV fragment (59 end-labeled at the NspV site). Protected fragments
were separated by 6% (7 M urea) polyacrylamide gel electrophoresis.
39 end-labeled fX-174 HaeIII fragments were used as molecular stan-
dards. The sizes of the protected fragments are indicated on the right.
(B) Transcription mapping of IE1. The same RNA samples as in A were
used for primer extension analyses of IE1. The positions of ie1 and ie0
transcripts are indicated on the right.
FIG. 4. In vitro translation of transcripts of the orf121 gene. orf121
transcripts were generated in vitro from pBS-ORF121 with T7 RNA
polymerase. In vitro translation was performed using wheat germ
extract. Molecular standards are marked on the left in kDa. The posi-
tion of the product of orf121 is shown on the right.
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was isolated from pPstL-AHD and then cloned into the
SmaI site of pBluescript (SK1), giving rise to pBS-ORF121.
Message-sense RNA transcripts of orf121 were gener-
ated using T7 RNA polymerase and translated in wheat
germ extracts in the presence of radiolabeled methio-
nine. A single polypeptide was detected after separation
of translation products by polyacrylamide gel electro-
phoresis (Fig. 4). Similar results were obtained using
rabbit reticulocyte extracts, although the migration of the
polypeptide was obscured by the presence of large
amounts of globin in the reticulocyte extracts (data not
shown).
ORF121 increased 39cat RNA levels
To determine whether the increase in CAT activity
correlated with an increase in 39cat mRNA, S1 nucle-
ase analyses and primer extension assays were per-
formed. Sf9 cells were cotransfected with p39cat and
pNheIE1 in the presence of pIE-ORF121 or the control
vector pIE1HcII. One-sixth of the transfected cells
were used to prepare extracts for CAT assays, while
the remaining 6 3 106 cells were used to isolate total
cell RNA. The levels of 39cat transcripts were deter-
mined by S1 nuclease and primer extension analyses.
The result of one primer extension assay is shown in
Fig. 5. This shows that cells cotransfected with pIE-
ORF121 had higher levels of 39cat mRNA than cells
transfected with the vector alone. Quantitation of re-
sults obtained by six separate determinations using
two different preparations of plasmids indicated that
this result was consistent. 39cat mRNA levels were
1.7 6 0.3-fold higher in cells transfected with pIE-
ORF121 than in the vector controls (Table 1). CAT
assays conducted at the same time indicated that
pIE-121 increased CAT activity by 3-fold.
ORF121 activates expression of IE1
The data presented in Fig. 1 show that ORF121 in-
creased expression from 39cat in the presence of IE1. To
test whether 39k activation required IE1, p39cat was
cotransfected with pIE-ORF121 or pIE1HcII (as a con-
trol) in the presence or the absence of pNheIE1. In the
absence of additional plasmids, CAT activity was at
background levels (Table 2) and was not significantly
increased by the addition of pIE-ORF121. In the presence
of IE1, pIE-ORF121 stimulated CAT activity 3.3-fold com-
pared to transfections with pIE1 alone.
Then we tested whether ORF121 could activate ie1
expression. The construct pIE1cat, which contains the
CAT gene under the control of the ie1 promoter, is active
in the absence of IE1, and thus it can be used to test
whether ORF121 requires IE1 for its stimulatory activity.
The plasmid pIE1cat was cotransfected with an equal
molar amount of pIE-ORF121 or pIE1HcII, in the pres-
ence or absence of 1 mg of pNheIE1 (Table 3). In the
absence of IE1, ORF121 increased expression from the
FIG. 5. ORF121 increases levels of 39cat RNA. S. frugiperda cells
(7 3 106/ml total) were transfected with 14 mg 39cat and 14 mg pNheIE1,
in the presence of equal molar amounts of pIE1HcII (25 mg) or
pIE-ORF121 (28 mg). Total RNA was prepared from 6 3 106 cells at 48 h
posttransfection. Cell extracts were prepared from 1 3 106 cells at the
same time for use in CAT assays. Total RNA (20 mg) was annealed to
a 59 end-labeled primer corresponding to an internal sequence of the
CAT gene. The signals corresponding to the 39cat mRNA were quan-
titated using a Fuji phosphoimager.
TABLE 1
Effect of ORF121 on Levels of 39cat mRNA
Transfected plasmids






pIE-ORF121 1.7 6 0.3 3.0 6 0.1
a Quantitation of mRNA levels were performed by primer extension
and S1 nuclease analysis. For S1 nuclease analysis, 20 mg of total RNA
was hybridized with a 59 end-labeled CAT gene-specific probe which
was prepared using the 218-bp EcoRI–EcoRI DNA fragment of p39cat.
Untransfected RNA was used to demonstrate the absence of protected
probe after S1 nuclease digestion. The signals corresponding to the
39cat mRNA were quantitated using a Fujix Bas2000 phosphorimaging
system.
b CAT assays were performed according to the liquid phase scintil-
lation counting method (Sambrook et al., 1989).
TABLE 2
Activation of 39cat Requires IE1
Transfected plasmidsa p39cat plus Relative CAT activity
pIE1HcII 1
pIE-ORF121 1.2
pIE1 1 pIE1HcII 3.5
pIE1 1 pIE-ORF121 (360 fmol) 11.7
a p39cat (1 mg) was cotransfected with equal molar amounts of
pIE-ORF121 or the parental vector pIE1HcII, in the presence or the
absence of pNheIE1 (1 mg). At least two different DNA preparations
were used for the assays. CAT assays were performed by thin-layer
chromatography and quantitated using a phosphorimager.
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ie1 promoter 1.7-fold (three experiments, each with du-
plicates or triplicates). In the presence of IE1, addition of
pIE-ORF121 increased CAT activity 3.1- to 4.1-fold, de-
pending on the concentration of input plasmid. These
data suggest that ORF121 activates expression from the
ie1 promoter.
We also tested whether the presence of a cis-linked
enhancer element on 39cat affected the activation of
39cat expression by ORF121. A reporter plasmid, p39cat-
Q2, which contains a viral enhancer element upstream
of the 39k promoter in p39cat (Guarino and Smith, 1992),
was cotransfected with vector or pIE-ORF121 in the pres-
ence of different amounts of pIE1. CAT assays were
performed using cell extracts prepared at 48 h posttrans-
fection. The relative increase of CAT activity due to pIE-
ORF121 was approximately equal to that observed in the
absence of enhancer (Fig. 6). These results indicated
that ORF121 activated 39k expression in an enhancer-
independent manner.
Comparison of 39cat activation by IE2, p35, and
ORF121
Our previous studies have shown that P35 and IE2 are
similar in that they both require IE1 to activate 39cat
expression, but they differ by the manner in which they
act, since addition of both IE2- and P35-expressing plas-
mids resulted in a synergistic effect (Gong and Guarino,
1994). Like IE2, ORF121 activates 39cat expression by
upregulating expression from the ie1 promoter. There-
fore, we wanted to compare the effect of adding different
combinations of ORF121, IE2, and P35 to transfection
assays (Table 4). p39cat was cotransfected with either 1
mg (Experiment 1) or 0.2 mg (Experiment 2) of pNheIE1
and different combinations of vector, pPstI-N (for the
expression of IE2), pEcoRI-S (for the expression of P35),
and pIE-ORF121. At both concentrations of IE1, the addi-
tion of plasmids encoding IE2 and P35 resulted in syn-
ergistic activation of 39cat expression which is consis-
tent with previous results. Addition of plasmids encoding
P35 and ORF121 also gave rise to a synergistic effect,
while the effects of IE2 and ORF121 were additive. Trans-
fection of all three plasmids encoding IE2, P35, and
ORF121 resulted in an increase in 39cat expression of
more than 100-fold. The data are consistent with the
hypothesis that ORF121 and IE2 both activate 39cat ex-
pression indirectly by increasing IE1 expression,
whereas P35 acts through a different pathway.
DISCUSSION
We found that cotransfection of pXhoI-G and IE1 re-
sulted in increased levels of CAT activity. We showed that
TABLE 3







pIE1HcII (360 fmol) 1 7
pIE-ORF121 (360 fmol) 1.7 6 0.1 6
pIE1 1 pIE1HcII (360 fmol) 1 2
pIE1 1 pIE-ORF121 (360 fmol) 3.1 2
pIE1 1 pIE1HcII (720 fmol) 1 2
pIE1 1 pIE-ORF121 (720 fmol) 4.1 2
a pIE1cat (1 mg) was cotransfected with equal molar amounts of
pIE-ORF121 or the parental vector pIE1HcII, in the presence or the
absence of pNheIE1 (1 mg). At least two different DNA preparations
were used for the assays. CAT assays were performed according to the
liquid phase scintillation counting method (Sambrook et al., 1989).
FIG. 6. Activation of 39cat expression by ORF121 in the presence of
a cis-linked enhancer. 1 mg p39cat-Q2 was cotransfected with 0.25 mg
of pIE1 and vector (lane 1) or pIE-ORF121 (lane 2).
TABLE 4
Activation of 39cat by ORF121, P35, and IE2 in the Presence of IE1
Transfected plasmids
p39cat 1 pIE1 plus
Relative CAT activitya




pPstI-N 1 pEcoRI-S 70.7 65.1
pIE-ORF121 3.0 5.2
pIE-ORF121 1 pPstI-N 14.8 18.7
pIE-ORF121 1 pEcoRI-S 17.1 21.9
pIE-ORF121 1 pEcoRI-S 1 pPstI-N 119.0 123.1
a All transfections were performed in duplicate. CAT assays were
performed using appropriate amounts of cell extract so that the reac-
tion was linear with respect to amount of enzyme added. Relative CAT
activity is expressed as the ratio of activity observed in cells trans-
fected with p39cat and pIE1 divided by that obtained in cells trans-
fected with the indicated plasmids.
b 1 mg p39cat and 1.0 mg pNheIE1 were cotransfected with 360 fmol
of the indicated plasmids.
c 1 mg p39cat and 0.2 mg pIE1 were cotransfected with 360 fmol of
the indicated plasmids.
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the factor responsible for the activation of 39cat is
present in a 370-bp AflIII DNA fragment which has two
ORFs (ORF121 and ORF122) that overlap in opposite
orientations. We believe that a trans-acting factor, the
product of the orf121 gene (ORF121), and not a cis-acting
DNA element was responsible for the increased expres-
sion of 39cat. This conclusion is supported by the fol-
lowing observations: (1) when the 370-bp AflIII fragment
was cloned in an orientation such that orf121 was under
the control of the ie1 promoter, the resulting plasmid,
pIE-ORF121, supported activation of 39cat expression,
while the plasmid pIE-ORF122 with ORF121 inserted in
the opposite orientation was not active and (2) an
ORF121 homolog is also present in another baculovirus,
Bombyx mori nuclear polyhedrosis virus (BmNPV), which
differs from the amino acid sequence of AcNPV ORF121
by only a few amino acids.
No homologs of ORF121 were identified in database
searches other than the BmNPV protein. The amino acid
sequence of ORF121 does not contain any obvious func-
tional motifs like nuclear localization signals, DNA/RNA
binding domains, or transcriptional activation domains.
Thus, we cannot predict the mechanisms by which
ORF121 activates gene expression from its amino acid
sequence.
The effect of ORF121 on 39cat was observed only in
the presence of IE1, the major transactivator for early
viral gene expression. This suggested to us that ORF121
might activate the 39k promoter indirectly by increasing
the expression of IE1 which is rate-limiting for transcrip-
tion of the 39k gene. To test this hypothesis, we per-
formed transient expression assays with pIE1cat. Our
studies indicated that ORF121 activated expression from
IE1cat 1.7-fold in the absence of IE1 and 3- to 4-fold in the
presence of IE1. This level of activation of IE1cat was
equivalent to that observed with 39cat and ORF121 in the
presence of IE1. Thus, activation of 39cat expression by
ORF121 can be explained by an increase in the level of
IE1 expression. However, the effect on 39cat expression
may not be solely due to stimulation of IE1 expression. It
is possible that ORF121, together with IE1, activates 39cat
expression directly, thus contributing to the upregulation
of 39cat. To investigate whether ORF121 is an accessory
factor, it is necessary to exclude the effect of ORF121 on
IE1 expression in the assays. It may be possible to
express IE1 using another promoter that is not affected
by ORF121 which would help to answer this question.
Baculovirus gene expression is regulated primarily by
transcriptional activation. Therefore, we favor the hypoth-
esis that ORF121 is a transcription factor, possibly a DNA
binding protein because of its basic nature. At only 58
amino acids, it would be the smallest baculovirus tran-
scription factor yet described. In addition to ORF121 and
IE1, at least two other proteins have been shown to
increase transient expression of the 39k promoter. These
are IE2, a transcription factor that stimulates expression
of IE1, and P35, an apoptotic suppressor. Comparative
studies showed that the effects of ORF121 and IE2 were
additive, while those of ORF121 and P35 were more than
additive. This suggests that ORF121 and IE2 may activate
through the same pathway, probably by increasing ex-
pression of IE1 which is rate-limiting for expression of
39k. The mechanism by which P35 increases 39cat ex-
pression is also indirect. P35 suppresses apoptosis and
thereby increases cell viability, which indirectly leads to
increased expression of target genes (Clem et al., 1991;
Clem and Miller, 1993). Apoptosis is induced either by
the transfection procedure itself or by expression of IE1
(Pridhod’ko and Miller, 1996).
Our model for the regulation of 39k gene expression is
a network in which multiple factors interact. IE1, the
major transactivator of early gene expression, plays a
key role in the regulation of 39k transcription. IE2 and
ORF121, stimulate ie1 expression, thus indirectly regulat-
ing 39k expression. Transcription of ie2 is transient and
precedes that of ie1, suggesting that IE2 is needed dur-
ing the earliest phase of viral infection. Transcripts of
orf121 accumulate more slowly than ie1 transcripts and
are longer lived than ie2 transcripts. This suggests that
ORF121 and IE2 may have the same function, but are
active at different times during viral infection.
MATERIALS AND METHODS
Construction of recombinant plasmids
pPstI-L and pPstI-M were cloned into the PstI site of
pUC8 and have been previously described (Carson et al.,
1988). To construct pPstL-AHD, pPstI-L was digested
with ApaI, and the 39 overhangs were removed with T4
DNA polymerase. The plasmid was then digested with
HindIII and the 59 ends were repaired with a DNA poly-
merase I large fragment (Klenow fragment) in the pres-
ence of dNTPs, and then the plasmid was religated. To
construct pPstL-ASD, pPstI-L was digested with ApaI,
treated with T4 DNA polymerase, then digested with
SmaI, and finally religated. To construct pPstL-EcoRV/FS,
pPstI-L was digested with EcoRV, treated with calf intes-
tinal phosphatase, and ligated with a 17-mer SmaI–HincII
fragment isolated from the vector pIBI24. To construct
pPst-AHDNcoI/FS, pPstL-AHD was digested with NcoI,
repaired with the Klenow fragment of Escherichia coli
DNA polymerase, and religated. In all of these cloning
strategies, plasmids were selected by restriction enzyme
digestion patterns.
To construct pIE-ORF121 and pIE-ORF122, a 370-bp AflIII
fragment containing both ORF121 and ORF122 was isolated
from pPstL-AHD by gel electrophoresis, filled in with Kle-
now polymerase, and cloned into the HincII site of
pIE1HcII. pIE1HcII was derived from pIE1 (Guarino and
Summers, 1986a) by digestion of pIE1 with HincII, followed
by religation. The orientations of the inserts relative to the
ie1 promoter were determined by restriction digestion. The
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orientation of pIE-ORF121 was also confirmed by sequenc-
ing. In pIE-ORF121 and pIE-ORF122, the ie1 promoter di-
rects the expression of ORF121 or ORF122, respectively. To
construct pBS-ORF121, a 370-bp AflIII fragment from pPstL-
AHD containing ORF121 was cloned into the SmaI site of
pBluescript (Stratagene). The orientation of the insert was
determined by restriction digestion and sequence analysis.
CAT assays
The conditions for cell culture have been described
previously (Summers and Smith, 1987). Transfections
with plasmid DNAs were performed according to Method
I of Summers and Smith (1987). At least two different
plasmid preparations were used for each assay. In the
initial stages of these experiments, CAT assays were
performed by thin-layer chromatographic (tlc) separation
of input chloramphenicol and the acetylated product as
previously described (Guarino and Summers, 1986a). In
later experiments, the CAT assays were performed by a
method based on diffusion of reaction products into
scintillation fluid (Sambrook et al., 1989). For these as-
says, cell pellets were resuspended in 100 ml of 100 mM
Tris–HCl (pH 7.8), and then 5 to 30 ml of cell extract was
diluted with 100 mM Tris–HCl (pH 7.8) to make final
volume of 50 ml. The diluted cell extract was added to a
7-ml glass scintillation vial and then heated for 15 min at
65°C. Two hundred microliters of freshly prepared CAT
reaction mix [0.125 M Tris–HCl (pH 7.8), 1.25 mM chlor-
amphenicol, 0.1 mCi of 3H-labeled acetyl coenzyme A (1.4
Ci/mmol; 50 mCi/ml)] was added to each vial. Then the
reaction mixes were carefully overlaid with 5 ml of a
water-immiscible scintillation fluid preincubated at 37°C,
followed by incubation at 37°C. The amount of radioac-
tivity in the scintillation fluid was counted for 6 s at
defined time intervals between 0 and 120 min.
S1 nuclease and primer extension assays
S1 nuclease analysis of AcNPV RNA was performed
as previously described (Sambrook et al., 1989). To
detect orf121 transcripts, a PstI–NspV fragment was 59
end-labeled using T4 polynucleotide kinase (Sam-
brook et al., 1989). Total cellular RNA was isolated
from AcNPV-infected S. frugiperda cells at defined
times from 0 to 48 h postinfection as described previ-
ously (Chirgwin et al., 1979; Guarino and Smith, 1992).
The DNA probe was hybridized to 20 mg of total RNA
at 42°C overnight after denaturation at 85°C for 15
min. Nonhybridized sequences were digested with 166
U/ml S1 nuclease at 37°C for 30 min, and protected
fragments were separated by 6% (7 M urea) polyacryl-
amide gel electrophoresis. The sizes of the protected
fragments were determined using 39 end-labeled fX-
174 HaeIII fragments as molecular standards. A se-
quencing ladder was generated using a primer that
had the same 59 end as the S1 probe.
For quantitation of 39cat mRNA, 20 mg of total RNA
was hybridized to a 59 end-labeled CAT gene-specific
probe which was prepared using a 218-bp EcoRI DNA
fragment from p39cat. S. frugiperda cells (1 3 106
cells/ml, 7 3 106 cells total) were transfected with
p39cat (14 mg total) and pNheIE1 (14 mg total) in the
presence of an equimolar amount of pIE1HcII (25.9
mg total) or pIE-ORF121 (28 mg total). Cell extracts
were prepared at 48 h posttransfection for CAT assay
and total RNA was prepared at the same time for S1
nuclease analysis and primer extension assays. S1
nuclease analysis of mRNA was performed as de-
scribed above. For primer extension assays, RNA was
annealed to a 59 end-labeled primer corresponding to
an internal sequence of the CAT gene. Primer exten-
sion was conducted using avian myeloblastosis virus
reverse transcriptase (Sambrook et al., 1989). The ex-
tended products were analyzed on 6% polyacryl-
amide–8 M urea gels. Sequencing ladders were gen-
erated using p39cat DNA and the same oligonucleo-
tide primer. For both S1 nuclease analysis and primer
extension, the signals corresponding to the 39cat
mRNA were quantitated using a Fujix Bax2000 phos-
phorimaging system.
In vitro translation
orf121 message-sense RNA transcripts were gener-
ated using T7 RNA polymerase and EcoRV-digested
pBS-ORF121. The RNA transcripts were purified by elec-
trophoresis in a low-melting-point agarose gel and
added to wheat germ extract (Promega Biotec., Madison,
WI) in the presence of [35S]methionine. The radiolabeled
peptides were analyzed by 13% SDS–polyacrylamide gel
electrophoresis (SDS–PAGE).
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